Tag: Cancer: Breast
Six Prognostic Factors ID’d for Invasive Disease After DCIS
Six significant factors include African-American race, premenopausal status, detection by palpation
Personalizing Breast Cancer Tx Could Cut Initial Costs of Care
Small decline seen in costs in first 12 months of care with personalized treatment based on recurrence scores
Recurrence Score May Cut Costs for High-Risk Breast Cancer Care
Testing with 21-gene assay linked to lower relative, absolute costs among high-risk patients
Genetic Testing Underused in Breast, Ovarian Cancer
Pathogenic variants ID'd in 7.8 percent of patients with breast cancer, 14.5 percent with ovarian cancer
Guidance Statements Issued for Breast Cancer Screening
Clinicians should discuss mammography with patients aged 40 to 49, discontinue screening for those ≥75
Ibrance Approval Expanded to Include Men With Breast Cancer
Kinase inhibitor approved in combination with endocrine therapy for male patients with breast cancer
AACR: Surgery Tied to Improved Survival in HER2+ Breast Cancer
In addition to targeted medication, adjuvant therapy, surgery improves survival in stage IV disease
State Breast Density Notification Laws May Up Ultrasound Use
But laws should require notification of possible benefits of supplemental screening
Digital Breast Tomosynthesis Can Reduce Benign Biopsy Rate
Fewer benign biopsies necessary with DBT compared with full-field digital mammography
Trastuzumab Tied to Higher Long-Term Risk for Heart Failure
Increased risk for heart failure seen in breast cancer survivors given trastuzumab rather than chemo alone
